IMARC Group has recently released a new research study titled “Europe Biopsy Devices Market: Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026”, offers a detailed analysis of the Europe biopsy devices market size, segmentation, growth opportunities, trends and competitive landscape to understand the current and future market scenarios.
We are in the process of updating our reports. If you want to receive the latest research data covering the time period from 2023 to 2028, along with industry trends, market size, and competitive analysis, click on the request sample report. The team would be able to deliver the latest version of the report in a quick turnaround time.
What is biopsy device?
Biopsy devices represent the various equipment that are used for the surgical extraction of tissues from an organ. They are utilized by radiologists, cardiologists, surgeons, and other medical practitioners to diagnose the presence or spread of diseases that are inflammatory or cancerous in nature. Commonly used equipment by biopsy devices include forceps, aspiration needles, guidance systems, and localization wires.
These machines are used in needle-based, core, MRI-guided, and vacuum-assisted biopsies of body parts, such as the kidneys, liver, lungs, and breasts. As a result, biopsy devices find widespread applications across medical clinics, healthcare institutions, diagnostic centers, and hospitals.
The escalating instances of chronic medical ailments, especially breast cancer, are among the primary factors driving the market. Besides this, the rising consumer awareness toward the availability of diagnostic and screening procedures for severe diseases is propelling the demand for integrated technologies, including stereotactic-guided biopsies, which is further augmenting the market growth.
The growing popularity of the MI breast biopsy technique (MIBT), as it eliminates the need for surgery for cancer diagnosis and preserves healthy tissues from damage caused by radiation, is also catalyzing the market across Europe. Apart from this, several technological advancements, such as the development of vacuum-assisted guns and smart systems that assist in distinguishing healthy cells from tumorous ones, are acting as significant growth-inducing factors.
The increasing preference for minimally invasive (MI) procedures among patients across the region is also stimulating the market growth. Furthermore, the elevating geriatric population, the inflating healthcare expenditure, and the ongoing research and development (R&D) activities are expected to bolster the Europe biopsy devices market in the coming years.
Request Free Sample Report: https://www.imarcgroup.com/europe-biopsy-devices-market/requestsample
Key Market Segmentation:
The report has segmented the Europe biopsy devices market based on procedure type, product, application, guidance technique, end user and country.
Breakup by Procedure Type:
- Surgical Biopsy
- Needle Biopsy
Breakup by Product:
- Biopsy Guidance Systems
- Needle Based Biopsy Guns
- Biopsy Needles
- Biopsy Forceps
Breakup by Application:
- Breast Biopsy
- Lung Biopsy
- Colorectal Biopsy
- Prostate Biopsy
Breakup by Guidance Technique:
- Ultrasound-guided Biopsy
- Stereotactic-guided Biopsy
- MRI-guided Biopsy
Breakup by End User:
- Hospitals and Clinics
- Academic and Research Institutes
Breakup by Country:
- United Kingdom
The competitive landscape of the Europe biopsy devices market has been studied in the report with the detailed profiles of the key players operating in the market.
Explore Full Report With TOC & List of Figures: https://www.imarcgroup.com/europe-biopsy-devices-market
Key Highlights of the Report:
- Market Performance (2015-2020)
- Market Outlook (2021-2026)
- Market Trends
- Market Drivers and Success Factors
- Impact of COVID-19
- Value Chain Analysis
- Comprehensive mapping of the competitive landscape
If you need specific information that is not currently within the scope of the report, we will provide it to you as a part of the customization.
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
Our offerings include comprehensive market intelligence in the form of research reports, production cost reports, feasibility studies, and consulting services. Our team, which includes experienced researchers and analysts from various industries, is dedicated to providing high-quality data and insights to our clientele, ranging from small and medium businesses to Fortune 1000 corporations.
Company Name: IMARC Group
Contact Person: Elena Anderson
Address: 134 N 4th St
Country: United States